Furthermore, lymphoma sequencing studies revealed that the network of concurrently mutated genes in MCD DLBCL cluster includes inactivating mutations of KLHL14, which promotes My-T-BCR-dependent NF-κB signaling via reduction of CD79a and CD79b ubiquitination [115]. The gene discussed is CD79B; the disease is diffuse large B-cell lymphoma.